Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost bought 25,600 shares of Opko Health stock in a transaction that occurred on Thursday, November 14th. The shares were purchased at an average price of $10.09 per share, for a total transaction of $258,304.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Several analysts have recently commented on the stock. Analysts at Jefferies Group raised their price target on shares of Opko Health from $10.00 to $11.50 in a research note to investors on Wednesday, November 13th. They now have a “buy” rating on the stock. Separately, analysts at Ladenburg Thalmann raised their price target on shares of Opko Health from $10.00 to $14.50 in a research note to investors on Wednesday, November 13th. They now have a “buy” rating on the stock. Finally, analysts at Barrington Research reiterated a “buy” rating on shares of Opko Health in a research note to investors on Monday, September 9th.
Opko Health (NYSE:OPK) opened at 10.05 on Monday. Opko Health has a 52 week low of $4.32 and a 52 week high of $12.95. The stock has a 50-day moving average of $10.35 and a 200-day moving average of $8.23. The company’s market cap is $4.100 billion.
OPKO Health, Inc (NYSE:OPK), incorporated in October 1991, is a multi-national pharmaceutical and diagnostics company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.